FAB
COM:FUSIONANTIBODIES
Fusion Antibodies
- Stock
Last Close
4.25
25/11 08:06
Market Cap
28.61K
Beta: -
Volume Today
160K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 35.13K - | 76.04K 116.44% | 162.24K 113.37% | 291.33K 79.57% | 410K 40.73% | 532.50K 29.88% | 561.50K 5.45% | 499.50K 11.04% | ||||
average payables | 241.58K - | 121.16K - | 172.02K 41.98% | 263.46K 53.16% | 371.55K 41.03% | 438.41K 17.99% | 379.50K 13.44% | 405K 6.72% | 473K 16.79% | 381.50K 19.34% | ||
average receivables | 476.50K - | 476.50K 0% | ||||||||||
book value per share | 0.01 - | 0.07 760.64% | 0.08 17.08% | 0.41 428.29% | 0.24 40.59% | 0.22 10.12% | 0.19 14.40% | 0.14 23.85% | 0.04 69.60% | 0.03 25.24% | ||
capex per share | -0.00 - | -0.00 219.38% | -0.00 152.43% | -0.03 575.07% | -0.06 126.55% | -0.00 92.10% | -0.01 190.57% | -0.01 30.64% | -0.00 55.93% | 0.00 100.82% | ||
capex to depreciation | -0.58 - | -1.61 179.15% | -2.74 70.14% | -6.39 133.36% | -3.20 49.86% | -0.18 94.53% | -0.51 191.71% | -0.34 32.80% | -0.31 10.80% | 0.01 102.97% | ||
capex to operating cash flow | 0.06 - | -0.10 267.77% | 2.42 2,440.78% | -5.76 338.46% | 1.26 121.82% | 0.68 45.80% | 0.32 52.84% | 0.79 147.07% | 0.06 91.81% | -0.00 101.74% | ||
capex to revenue | -0.01 - | -0.02 96.06% | -0.05 95.36% | -0.17 250.33% | -0.63 282.95% | -0.03 95.58% | -0.09 213.15% | -0.05 38.65% | -0.04 26.90% | 0.00 104.48% | ||
cash per share | 0.00 - | 0.02 299.44% | 0.01 30.98% | 0.28 2,054.66% | 0.09 67.76% | 0.07 22.54% | 0.11 51.64% | 0.08 25.15% | 0.01 90.51% | 0.02 187.92% | ||
days of inventory on hand | 26.93 - | 24.73 8.14% | 64.28 159.90% | 58.46 9.07% | 81.83 39.99% | 91.52 11.84% | 84.39 7.80% | 119.84 42.01% | ||||
days payables outstanding | 255.83 - | 114.09 55.40% | 58.11 49.07% | 94.13 61.99% | 85.04 9.66% | 122.34 43.87% | 71.35 41.68% | 58.65 17.81% | 72.91 24.32% | 75.29 3.27% | 73.73 2.07% | |
days sales outstanding | 119.91 - | |||||||||||
debt to assets | 0.01 - | 0.02 107.94% | 0.06 182.20% | 0.04 37.29% | 0.01 64.42% | 0.04 159.09% | ||||||
debt to equity | 0.01 - | 0.03 121.14% | 0.08 203.80% | 0.05 38.64% | 0.02 61.34% | 0.07 256.58% | ||||||
dividend yield | ||||||||||||
earnings yield | -0.00 - | 0.04 1,455.97% | 0.00 89.61% | -0.04 1,036.25% | -0.20 387.86% | -0.03 83.46% | -0.07 118.38% | -0.08 6.28% | -0.26 236.25% | -1.04 301.52% | ||
enterprise value | -139.09K - | 27.18M 19,640.44% | 26.87M 1.14% | 27.00M 0.48% | 12.59M 53.37% | 4.45M 64.65% | 19.83M 345.53% | 37.51M 89.18% | 13.59M 63.78% | 9.90M 27.17% | 982.91K 90.07% | |
enterprise value over ebitda | 1.38 - | -342.52 24,994.47% | 538.22 257.14% | 169.24 68.56% | -19.77 111.68% | -4.18 78.85% | -46.01 1,000.51% | -70.52 53.27% | -23.71 66.37% | -3.99 83.19% | -0.48 88.05% | |
ev to operating cash flow | -149.29 - | 77.53 151.93% | -722.35 1,031.73% | 163.10 122.58% | -4.05 102.48% | -123.94 2,958.40% | -33.02 73.35% | -41.81 26.60% | -5.64 86.51% | -0.56 90.15% | ||
ev to sales | -0.19 - | 29.89 15,638.03% | 18.14 39.31% | 14.11 22.24% | 4.68 66.83% | 2.04 56.40% | 5.09 149.57% | 9.01 76.92% | 2.83 68.57% | 3.41 20.48% | 0.87 74.64% | |
free cash flow per share | -0.01 - | 0.01 260.84% | -0.01 141.07% | -0.02 294.52% | -0.11 392.26% | -0.01 89.15% | -0.06 384.18% | -0.02 61.89% | -0.07 219.56% | -0.03 55.61% | ||
free cash flow yield | -0.01 - | 0.01 260.84% | -0.00 141.07% | -0.02 361.83% | -0.39 1,722.21% | -0.01 96.74% | -0.04 192.98% | -0.04 0.27% | -0.19 398.02% | -0.83 343.95% | ||
graham net net | -0.00 - | 0.00 102.57% | -0.01 5,245.19% | 0.24 4,229.14% | 0.06 77.22% | 0.02 60.65% | 0.07 233.87% | 0.04 40.88% | 0.01 78.47% | 0.01 56.64% | ||
graham number | 0.03 - | 0.28 980.28% | 0.10 65.12% | 0.63 550.01% | 0.56 11.51% | 0.39 29.61% | 0.69 75.77% | 0.38 44.39% | 0.31 19.01% | 0.17 45.21% | ||
income quality | 2.14 - | 0.30 85.96% | -0.31 203.75% | -0.11 64.60% | 0.87 887.68% | 0.23 73.57% | 0.39 70.70% | 0.27 30.89% | 0.68 149.47% | 0.79 17.62% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.00 Infinity% | 0.00 33.47% | 0.00 48.20% | 0 100% | 0 | 0 | |
interest coverage | -112.99 - | -148.55 31.48% | 55.82 137.57% | 205.74 268.60% | -146.14 171.03% | -374.02 155.93% | -52.95 85.84% | -69.39 31.05% | -147.22 112.17% | -714.50 385.32% | -457.60 35.96% | |
interest debt per share | 0.00 - | 0.00 25.41% | 0.00 23.99% | 0.01 18,208.66% | 0.01 27.18% | 0.02 179.31% | 0.01 46.20% | 0.00 69.14% | 0.00 1.01% | 0.00 97.04% | ||
inventory turnover | 13.56 - | 14.76 8.86% | 5.68 61.52% | 6.24 9.97% | 4.46 28.57% | 3.99 10.59% | 4.33 8.46% | 3.05 29.58% | ||||
invested capital | 0.01 - | 0.03 121.14% | 0.08 203.80% | 0.05 38.64% | 0.02 61.34% | 0.07 256.58% | 1.84M 2,749,103,900% | |||||
market cap | 27.28M - | 27.28M 0% | 27.28M 0% | 17.00M 37.68% | 6.30M 62.97% | 20.99M 233.33% | 39.97M 90.46% | 15.57M 61.05% | 10.02M 35.66% | 2.14M 78.64% | ||
net current asset value | -28.36K - | 132.85K 568.36% | 280.14K 110.87% | 479.81K 71.27% | 4.87M 915.47% | 2.42M 50.38% | 1.57M 34.89% | 3.62M 130.11% | 3.05M 15.76% | 748K 75.48% | 1.64M 118.58% | |
net debt to ebitda | 1.38 - | 1.31 5.08% | -8.29 734.92% | -1.79 78.40% | 6.93 486.96% | 1.73 74.99% | 2.68 54.89% | 4.62 71.97% | 3.46 25.15% | 0.05 98.60% | 0.56 1,058.89% | |
net income per share | -0.00 - | 0.05 1,455.97% | 0.01 89.61% | -0.04 899.79% | -0.06 31.79% | -0.03 44.87% | -0.11 260.91% | -0.05 59.38% | -0.10 115.76% | -0.04 59.85% | ||
operating cash flow per share | -0.01 - | 0.02 290.37% | -0.00 110.78% | 0.00 383.09% | -0.05 1,138.10% | -0.01 85.43% | -0.04 516.08% | -0.01 71.93% | -0.07 438.26% | -0.03 52.77% | ||
payables turnover | 1.43 - | 3.20 124.24% | 6.28 96.33% | 3.88 38.27% | 4.29 10.69% | 2.98 30.49% | 5.12 71.47% | 6.22 21.66% | 5.01 19.56% | 4.85 3.17% | 4.95 2.12% | |
receivables turnover | 3.04 - | |||||||||||
research and ddevelopement to revenue | 0.22 - | 0.28 - | 0.22 19.52% | |||||||||
return on tangible assets | -0.36 - | -0.23 36.57% | 0.62 369.21% | 0.06 90.99% | -0.10 274.53% | -0.20 108.80% | -0.12 43.04% | -0.50 330.77% | -0.24 50.92% | -1.26 415.65% | -0.92 26.94% | |
revenue per share | 0.04 - | 0.07 62.90% | 0.09 29.21% | 0.17 92.69% | 0.10 40.84% | 0.18 78.52% | 0.16 7.21% | 0.18 13.06% | 0.11 39.71% | 0.02 81.66% | ||
roe | 0.02 - | -0.50 2,766.80% | 0.79 257.55% | 0.07 91.12% | -0.11 251.39% | -0.24 121.84% | -0.14 38.66% | -0.61 321.62% | -0.33 46.66% | -2.31 609.68% | -1.24 46.29% | |
roic | 0.02 - | -0.50 2,481.14% | 0.81 261.51% | 0.07 91.24% | -0.11 248.74% | -0.23 114.82% | -0.12 45.32% | -0.55 345.61% | -0.31 43.27% | -2.04 553.20% | -1.24 39.13% | |
sales general and administrative to revenue | 0.45 - | 0.63 38.93% | 0.57 9.04% | 0.46 19.12% | 0.84 81.62% | 1.10 31.57% | 0.74 32.58% | 0.83 12.31% | 0.80 4.35% | 1.19 49.06% | 1.98 66.66% | |
shareholders equity per share | 0.01 - | 0.07 760.64% | 0.08 17.08% | 0.41 428.29% | 0.24 40.59% | 0.22 10.12% | 0.19 14.40% | 0.14 23.85% | 0.04 69.60% | 0.03 25.24% | ||
stock based compensation to revenue | 0.11 - | 0.09 17.67% | 0.07 25.32% | 0.12 82.13% | 0.04 63.53% | 0.02 52.38% | 0.00 78.59% | 0.00 4.08% | 0.01 175.71% | 0.08 527.48% | ||
tangible asset value | 16.32K - | 169.29K 937.34% | 1.46M 760.64% | 1.71M 17.08% | 6.58M 285.43% | 5.35M 18.66% | 4.81M 10.10% | 4.75M 1.31% | 3.68M 22.36% | 1.12M 69.52% | 1.79M 59.66% | |
tangible book value per share | 0.01 - | 0.07 760.64% | 0.08 17.08% | 0.41 428.29% | 0.24 40.66% | 0.22 10.10% | 0.19 14.36% | 0.14 23.82% | 0.04 69.60% | 0.03 25.24% | ||
working capital | -28.36K - | 152.85K 638.88% | 300.14K 96.37% | 499.81K 66.52% | 4.94M 887.55% | 2.51M 49.14% | 1.81M 27.77% | 3.71M 104.58% | 3.07M 17.12% | 808K 73.72% | 1.68M 107.67% |
All numbers in GBP (except ratios and percentages)